SIREN : 832222053
ALTADIGE GROUPE DEROMEDI is a French company founded 8 years ago, specialized in the sector Supports juridiques de programmes. Based in PARIS (75016), this company of category PME shows in 2024 a revenue of 767 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 767 124 € | 755 068 € | 1 488 669 € | 706 431 € | 692 074 € | 563 367 € | 752 636 € |
| Net income | 819 903 € | 592 525 € | 2 180 229 € | 1 071 907 € | 201 410 € | 2 140 859 € | 1 004 327 € |
| EBITDA | -556 112 € | -308 685 € | 174 929 € | -257 767 € | -210 107 € | -280 865 € | 43 650 € |
| Net margin | 106.9% | 78.5% | 146.5% | 151.7% | 29.1% | 380.0% | 133.4% |
In 2024, ALTADIGE GROUPE DEROMEDI achieves revenue of 767 k€. Revenue is growing positively over 7 years (CAGR: +0.3%). Vs 2023: +2%. After deducting consumption (0 €), gross margin stands at 767 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -556 k€, representing -72.5% of revenue. Warning negative scissor effect: despite revenue change (+2%), EBITDA varies by -80%, reducing margin by 31.6 pts. This reflects costs rising faster than revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 820 k€, i.e. 106.9% of revenue. This profit can be retained or distributed to shareholders.
767 124 €
767 124 €
-556 112 €
-578 958 €
819 903 €
-72.5%
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 99%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Cash flow represents 101.4% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
0.0%
99.093%
101.449%
0.0
70.1%
In 2024, the debt ratio of ALTADIGE GROUPE DEROMEDI (0.00) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2024, the financial autonomy of ALTADIGE GROUPE DEROMEDI (99.1%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2024, the repayment capacity of ALTADIGE GROUPE DEROMEDI (0.00) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
The liquidity ratio (= Current assets / Current liabilities) stands at 2559.94. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
2559.936
0.0
In 2024, the liquidity ratio of ALTADIGE GROUPE DEROMEDI (2559.94) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
In 2024, the interest coverage of ALTADIGE GROUPE DEROMEDI (0.0x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 101 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 78 days. The company must finance 23 days of gap between collections and payments. Overall, WCR represents 177 days of revenue, i.e. 376 k€ to permanently finance. Notable WCR improvement over the period (-25%), freeing up cash.
376 343 €
101 j
78 j
0 j
177 j
Based on 80 transactions of similar company sales
(all years),
the value of ALTADIGE GROUPE DEROMEDI is estimated at
898 985 €
(range 285 563€ - 2 435 870€).
The price/revenue ratio is 0.28x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 80 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare ALTADIGE GROUPE DEROMEDI with other companies in the same sector:
Voir toutes les statistiques du secteur Supports juridiques de programmes
The revenue of ALTADIGE GROUPE DEROMEDI in 2024 is 767 k€.
Yes, ALTADIGE GROUPE DEROMEDI generated a net profit of 820 k€ in 2024.
The headquarters of ALTADIGE GROUPE DEROMEDI is located in PARIS (75016), in the department Paris.
The tax return of ALTADIGE GROUPE DEROMEDI is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
ALTADIGE GROUPE DEROMEDI operates in the sector Supports juridiques de programmes (NAF code 41.10D). See the 'Sector positioning' section above to compare the company with its competitors.